Cognitive performance in methadone maintenance patients: Effects of time relative to dosing and maintenance dose level.

Abstract

Given the long-term nature of methadone maintenance treatment, it is important to assess the extent of cognitive side effects. This study investigated cognitive and psychomotor performance in fifty-one methadone maintenance patients (MMP) as a function of time since last methadone dose and maintenance dose level. MMP maintained on doses ranging from 40 to 200 mg (Mean = 97 mg) completed a battery of psychomotor and cognitive measures across two sessions, during peak and trough states, in a double-blind crossover design. Peak sessions were associated with worse performance on measures of sensory processing, psychomotor speed, divided attention, and working memory, compared to trough sessions. The effects of maintenance dose were mixed, with higher dose resulting in worse performance on aspects of attention and working memory, improved performance on executive function, and no effects on several measures. Longer treatment duration was associated with better performance on some measures, but was also associated with increased sensitivity to time since last dose (i.e., worse performance at peak vs. trough) on some measures. The results suggest that cognitive functioning can fluctuate as a function of time since last dose even in MMP who have been maintained on stable doses for an extended time (mean duration in treatment = 4 years), but worsened performance at peak is limited to a subset of functions and may not be clinically significant at these modest levels of behavioral effect. For patients on stable methadone maintenance doses, maintenance at higher doses may not significantly increase the risk of performance impairment.

Methadone maintenance patients show a selective deficit to reverse positive outcomes in drug-related conditions compared to medication free prolonged opiate abstinence

“…Specifically, one may claim that the impaired performance of the methadone maintenance patients is due to timing of methadone administration. Rass et al (2014) have found that methadone negatively affects physiological and cognitive functioning. These effects are evident 1 h after dose administration and reach peak at approximately 2 h post dose.…”

Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective

“…For example, methadone, which has been widely prescribed for opioid users, can have both positive and negative outcomes (Rass et al, 2014). …”

Suppressor capacity of iron nanoparticles biosynthesized using Salvia chloroleuca leaf aqueous extract on methadone‐induced cell death in PC12: Formulation a new drug from relationship between the nanobiotechnology and neurology sciences

“…The cells exposed to methadone exhibited some changes, including high permeability of the mitochondrial outer membrane and transfer of BAX into mitochondria, which also lead to the release of cytochrome C . A study on mitochondria of methadone‐treated rat livers showed that methadone causes mitochondrial uncoupling and also has ion transferability, so it induces cell death due to its ability to significantly decrease cellular ATP levels . Increasing the production of reactive oxygen species, as well as increasing calcium, plays an important role in inducing the cell death.…”